Pseudocholinesterase deficiency

From WikiMD's WELLNESSPEDIA


Pseudocholinesterase deficiency
Synonyms Butyrylcholinesterase deficiency, Plasma cholinesterase deficiency
Pronounce N/A
Specialty N/A
Symptoms Prolonged muscle relaxation, apnea
Complications Respiratory failure, prolonged paralysis
Onset Congenital
Duration Variable, depending on exposure to triggering agents
Types N/A
Causes Genetic mutation in the BCHE gene
Risks Family history, genetic predisposition
Diagnosis Dibucaine number test, genetic testing
Differential diagnosis Myasthenia gravis, Lambert-Eaton myasthenic syndrome
Prevention N/A
Treatment Supportive care, mechanical ventilation if needed
Medication Avoidance of succinylcholine and mivacurium
Prognosis N/A
Frequency 1 in 3,200 to 1 in 5,000 individuals
Deaths Rare, if managed appropriately


Pseudocholinesterase deficiency is a medical condition that is characterized by an atypical reaction to certain drugs used during general anesthesia, such as the muscle relaxants succinylcholine and mivacurium as well as certain ester local anesthetics. The condition is inherited in an autosomal recessive manner. This means the deficient individual must have two copies of the abnormal gene for the disease to develop.

Signs and Symptoms[edit]

The primary sign of pseudocholinesterase deficiency is an extended period of muscle paralysis or weakness following the administration of anesthesia. This can lead to difficulty breathing if the muscles that control breathing are affected.

Causes[edit]

Pseudocholinesterase deficiency is caused by a mutation in the BCHE gene. This gene provides instructions for making a protein called butyrylcholinesterase, which is responsible for breaking down certain drugs used during general anesthesia.

Diagnosis[edit]

The diagnosis of pseudocholinesterase deficiency usually occurs after a person has had a reaction to anesthesia. Blood tests can be done to measure the level of pseudocholinesterase in the blood.

Treatment[edit]

There is no cure for pseudocholinesterase deficiency. Management of the condition involves avoiding certain drugs that can cause a reaction. In cases where these drugs have been administered, mechanical ventilation may be required to assist with breathing until the drugs have been metabolically cleared.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.